Active Biotech
0.07 SEK
-1.54 %
Less than 1K followers
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-1.54 %
+5.87 %
+44.06 %
+52.83 %
+21.63 %
-63.24 %
-72.70 %
-84.05 %
-98.30 %
Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The project portfolio includes both small, orally active immunomodulatory molecules and antibody-based immunotherapy. The company operates globally. Active Biotech was founded in 1998 and is headquartered in Lund.
Read moreMarket cap
185.32M SEK
Turnover
243.15K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
5.11
2026
Interim report Q3'26
11.2
2027
Annual report '26
All
Webcasts
Press releases
ShowingAll content types
European regulatory approval obtained to resume enrolment in the HOVON 172 MF study evaluating tasquinimod in myelofibrosis and conducted in collaboration between Active Biotech, Oncode and HOVON
Redeye: Active Biotech (Q1 Review): Intensified Focus on Business Development
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools